Coverage
-
November 20, 2020
A New York federal judge gave preliminary approval Thursday to a $1.75 million class action settlement that would end litigation alleging Canadian pharmaceutical company Correvio Pharma Corp. misled shareholders about the likelihood of a heart drug gaining approval by the U.S. Food and Drug Administration.
1 other articles on this case.
View all »